Chronic Urticaria Market Size: Epidemiology, Industry Trends, Opportunity and Forecast till 2023-2033

IMARC Group has recently released a report titled “Chronic Urticaria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033” that presents a comprehensive assessment of the chronic urticaria market size, latest trends, and growth forecast. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends.

Chronic urticaria represents a common dermal disorder usually characterized by severely inflamed, well-encircled, and swollen welts with sizes that range from a few millimeters to various centimeters or wider. It is generally caused by the secretion of excessive quantities of histamine and other inflammatory mediators in the skin. The diagnosis of chronic urticaria is primarily clinical. In addition to this, a physical examination includes evaluating the pulse rate and characterizing as well as identifying present lesions and their severity with the help of a skin biopsy.

Request a Free Sample Report: https://www.imarcgroup.com/chronic-urticaria-market/requestsample

Market Trend:

The rising prevalence of allergic disorders and infections, owing to numerous associated triggering factors, such as alcohol, heat and friction, diet, mental stress, etc., is primarily driving the chronic urticaria market. Additionally, the growing incidences of autoimmune ailments, such as rheumatoid arthritis, Type 1 diabetes, celiac disease, etc., are further catalyzing the market growth. Besides this, non-governmental organizations (NGOs) and government bodies across countries are launching health education campaigns to generate awareness regarding the psychosocial effects of chronic urticaria, especially stigmatization, which is acting as another significant growth-inducing factor.

Moreover, the introduction of advanced validated instruments that can quantify the severity of the ailment is also positively influencing the global market. Apart from this, the increasing investments in R&D activities to evaluate the safety and efficacy, mechanism of action, and dosing of biologics are bolstering the market growth. Furthermore, the inflating popularity of second-generation antihistamines and the development of pharmacological and preventive approaches to control the disabling symptoms suffered by patients are anticipated to fuel the chronic urticaria market over the forecasted period.

Report Period:

Base Year: 2022

Historical Period: 2017-2022

Market Forecast: 2023-2033

Countries Included:

United States

Germany

France

United Kingdom

Italy

Spain

Japan

Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario

Historical, current, and future performance of the chronic urticaria market

Historical, current, and future performance of various therapeutic categories in the market

Sales of various drugs across the chronic urticaria market

Reimbursement scenario in the market

In-market and pipeline drugs

In-Market Drugs

Drug Overview

Mechanism of Action

Regulatory Status

Clinical Trial Results

Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview

Mechanism of Action

Regulatory Status

Clinical Trial Results

Regulatory Status

Ask an Analyst for Report Customization with TOC & List of figures: https://www.imarcgroup.com/chronic-urticaria-market

Key Questions Answered in this Report:

How has the chronic urticaria market performed so far and how will it perform in the coming years?

What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?

What was the country-wise size of the chronic urticaria market across the seven major markets in 2022 and what will it look like in 2033?

What is the growth rate of the chronic urticaria market across the seven major markets and what will be the expected growth over the next ten years?

What are the key unmet needs in the market?

About Us: –

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St.

Brooklyn, NY 11249, USA

Email: [email protected]

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800